{"product_id":"kao-bcg-matrix","title":"Kao Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClarify Kao's Portfolio Positioning with the BCG Matrix\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eThe Kao BCG Matrix snapshot maps the company's brands and product lines into Stars, Cash Cows, Question Marks, and Dogs, revealing growth trajectories and resource priorities at a glance. This concise preview shows which categories drive market share and which may require additional investment or consideration for divestment. The full BCG Matrix delivers quadrant-level data, tailored strategic options for Kao's beauty, health, fabric and chemical portfolios, and practical recommendations you can implement immediately. Purchase the complete report for a ready-to-use Word analysis and an Excel summary to present and act on with confidence.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCurél Derma Care\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAs of late 2025 Curél Derma Care is a Star in Kao's BCG matrix, posting a 70% year‑on‑year sales jump in the UK in H1 2025 and contributing materially to Kao's skin care growth.\u003c\/p\u003e\n\u003cp\u003eUnder K27 Kao plans a sixfold expansion of European stores in 2025-27 to capture the £3.4bn (2024) sensitive‑skin segment, driving rapid international share gains.\u003c\/p\u003e\n\u003cp\u003eHigh niche share plus fast growth forces heavy marketing spend-estimated tens of millions GBP annually-to sustain momentum toward global leadership.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBioré UV Sun Care\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBioré UV Sun Care is a Star in Kao's BCG matrix, dominating Japan's UV market with a ~35% share in 2024 and leading category growth at ~6% CAGR (2021-24).\u003c\/p\u003e\n\u003cp\u003eIn 2025 Bioré expanded into Brazil through a distribution JV, adding ~€40m in addressable revenue potential in LATAM and tapping 5-7% regional sunscreen growth.\u003c\/p\u003e\n\u003cp\u003eDespite fierce rivals like Shiseido and local brands, continuous Aqua Protect tech rollouts drive repeat purchases and support premium ASPs, keeping Bioré a high-share, high-growth asset.\u003c\/p\u003e\n\u003cp\u003eThe brand consumes cash for global placement-marketing and channel investment ~€60m in 2024-but projects double-digit IRR from scale and cross-market synergies by 2027.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eKANEBO Prestige Cosmetics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eKANEBO Prestige Cosmetics drives Kao's 2025 cosmetics push, posting 113% year-on-year sales growth among focus brands and contributing to Kao's cosmetics segment rebound to ¥280 billion in FY2025 H1.\u003c\/p\u003e\n\u003cp\u003ePlaced as a Star in the BCG matrix, KANEBO targets the high-growth luxury\/prestige market-Asia rollout underway with a Thailand pilot in Q2 2025 to build a regional blueprint and capture a 5-8% premium-skincare share.\u003c\/p\u003e\n\u003cp\u003eThe brand needs heavy investment: ¥6-8 billion capex over 2025-2026 for premium positioning, retail upgrades, and AI-driven CRM\/sales tools to protect and expand its leading share in a growing segment expected to CAGR 7-9% through 2028.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMelt and The Answer Hair Care\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMelt (launched 2024) and The Answer Hair Care (launched 2025) are Stars in Kao's BCG matrix, capturing ~18% combined shipment share of Japan's premium hair care segment and growing at ~35% CAGR in 2024-25.\u003c\/p\u003e\n\u003cp\u003eThey mark Kao's move to high-value growth-focusing on emotional well-being and premium self-care-with average selling prices 40-60% above Kao's core range and gross margins near 58% in 2025.\u003c\/p\u003e\n\u003cp\u003eHigh growth demands ongoing promo and A\u0026amp;P; Kao increased brand support by ¥6.5bn in FY2024-25 to defend share versus LVMH-owned and Shiseido prestige lines.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLaunched: Melt 2024, The Answer 2025\u003c\/li\u003e\n\u003cli\u003eCombined shipment share: ~18% (premium Japan)\u003c\/li\u003e\n\u003cli\u003eGrowth: ~35% CAGR (2024-25)\u003c\/li\u003e\n\u003cli\u003eASP premium: +40-60%; gross margin ~58% (2025)\u003c\/li\u003e\n\u003cli\u003eIncremental A\u0026amp;P: ¥6.5bn FY2024-25\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eChemical Division Semiconductor Materials\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eKao's Chemical Division-Semiconductor Materials is a Star: materials for semiconductor manufacturing saw steady demand and price upticks in 2025, with Kao reporting ~8-12% segment revenue growth year‑on‑year and mid‑single‑digit margin expansion driven by specialty photoresists and cleaning agents.\u003c\/p\u003e\n\u003cp\u003eThe unit uses Kao's interface science to sustain a technology lead, gets targeted R\u0026amp;D funding (~¥3-5 billion planned in 2025) and supports group profitability as a high‑growth, high‑market‑share business.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2025 revenue growth: 8-12%\u003c\/li\u003e\n\u003cli\u003eR\u0026amp;D allocation: ~¥3-5 billion\u003c\/li\u003e\n\u003cli\u003eDrivers: photoresists, cleaning agents, interface science edge\u003c\/li\u003e\n\u003cli\u003eStatus: high growth, high share (Star)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eKao 2025: Curél, Bioré UV, KANEBO \u0026amp; Semiconductors Power High-Growth Revenue\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStars: Curél, Bioré UV, KANEBO, Melt\/The Answer, Semiconductor Materials-high-share, high-growth units driving Kao's 2025 top-line; combined A\u0026amp;P\/capex ~¥13-¥15bn, semiconductor R\u0026amp;D ¥3-5bn, Bioré marketing ~€60m, Curél UK +70% H1 2025.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eBrand\/Unit\u003c\/th\u003e\n\u003cth\u003eGrowth\u003c\/th\u003e\n\u003cth\u003e2025 Spend\u003c\/th\u003e\n\u003cth\u003eShare\/ASP\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCurél UK\u003c\/td\u003e\n\u003ctd\u003e+70% H1\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBioré UV\u003c\/td\u003e\n\u003ctd\u003e~6% CAGR\u003c\/td\u003e\n\u003ctd\u003e€60m\u003c\/td\u003e\n\u003ctd\u003e~35% JP\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eKANEBO\u003c\/td\u003e\n\u003ctd\u003e+113% Y\/Y\u003c\/td\u003e\n\u003ctd\u003e¥6-8bn\u003c\/td\u003e\n\u003ctd\u003epremium\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHair Brands\u003c\/td\u003e\n\u003ctd\u003e~35% CAGR\u003c\/td\u003e\n\u003ctd\u003e¥6.5bn\u003c\/td\u003e\n\u003ctd\u003eASP +40-60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSemiconductor\u003c\/td\u003e\n\u003ctd\u003e8-12%\u003c\/td\u003e\n\u003ctd\u003e¥3-5bn\u003c\/td\u003e\n\u003ctd\u003ehigh share\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eComprehensive BCG Matrix review of Kao's portfolio with quadrant strategies, investment recommendations, and trend-driven risks and advantages.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page BCG matrix placing Kao's business units in clear quadrants for quick strategic decisions\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAttack Laundry Detergents\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAttack Laundry Detergents is Kao's Cash Cow, holding a 46% share of Japan's laundry detergent market as of end-2025 and generating stable operating cash flow with single-digit annual volume declines in the mature domestic market.\u003c\/p\u003e\n\u003cp\u003eWith domestic market growth near 0-1% (2025), Attack needs minimal capex; free cash flow funded 2025 R\u0026amp;D and global rollouts, covering roughly ¥40-60 billion of internal investment that year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eKitchen Care and Cleansers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eKao's Kitchen Care and Cleansers hold a 52% share of Japan's kitchen care market (2025 retail data), delivering stable earnings and ~18-22% segment EBITDA margins that fund dividends and interest-cash generation offsets low category growth (~1% CAGR). \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLaurier Sanitary Products\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eLaurier Sanitary Products remains a market leader in Japan and key Asian markets, holding estimated market shares of ~30-40% in Japan and 15-25% in Southeast Asia as of 2025, which classifies it as a Cash Cow in Kao's BCG matrix.\u003c\/p\u003e\n\u003cp\u003eThe sanitary category is mature, but Laurier's brand equity drives steady gross margins around 35% and mid-single-digit annual revenue growth, despite intensified price competition in SEA.\u003c\/p\u003e\n\u003cp\u003eKao prioritizes high-loyalty, targeted marketing over mass reach, keeping customer retention above 70% and lowering acquisition costs, so Laurier reliably funds Kao's Business Transformation programs through stable free cash flow.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMerries Diapers (Japan)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAfter restructuring, Merries (Kao Corp., Tokyo Stock Exchange: 4452) has stabilized as a Cash Cow in Japan, targeting profitability and premium diapers; Kao reported babycare segment operating income up 4.2% in FY2024 (year to Mar 2024), with Merries sustaining ~25-30% share in premium diaper value in Japan per Euromonitor 2024.\u003c\/p\u003e\n\u003cp\u003eDomestic infant-care growth is low (~0-1% CAGR 2022-24), but Merries' strong margin profile contributes materially to Kao's group operating income-estimated steady cash inflow covering R\u0026amp;D and marketing.\u003c\/p\u003e\n\u003cp\u003eThe brand's shift to a light-asset international model (licensing\/distribution) since 2022 cuts capex and protects domestic cash flow, supporting reinvestment into premium positioning and margin preservation.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFY2024 babycare OP +4.2%\u003c\/li\u003e\n\u003cli\u003eMerries premium diaper share ~25-30% (Euromonitor 2024)\u003c\/li\u003e\n\u003cli\u003eJapan infant-care growth ~0-1% CAGR 2022-24\u003c\/li\u003e\n\u003cli\u003eLight-asset international model reduces capex, preserves domestic cash\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMegRhythm Steam Eye Masks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMegRhythm Steam Eye Masks function as a Cash Cow for Kao, dominating Japan and major Asian cities within the wellness and relaxation niche, with estimated category share of 40-55% in urban Japan as of 2025.\u003c\/p\u003e\n\u003cp\u003eThe product is at market maturity, showing consistent repurchase rates around 60-70% yearly and requiring low promotional spend-marketing intensity under 5% of sales in 2024.\u003c\/p\u003e\n\u003cp\u003eSteady gross margins near 48% in 2024 generate predictable cash flow that Kao channels into higher-risk human health care R\u0026amp;D and M\u0026amp;A.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket share: 40-55% (urban Japan, 2025)\u003c\/li\u003e\n\u003cli\u003eRepurchase rate: 60-70% yearly\u003c\/li\u003e\n\u003cli\u003eMarketing spend: \u0026lt;5% of sales (2024)\u003c\/li\u003e\n\u003cli\u003eGross margin: ~48% (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eKao's Cash Cows: High-Margin Brands Power Steady Free Cash Flow\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eKao's Cash Cows-Attack detergent, Kitchen Care\/Cleansers, Laurier, Merries, MegRhythm-deliver steady free cash flow (2025): Attack 46% Japan share; Kitchen Care 52% share, 18-22% EBITDA; Laurier 30-40% Japan, 15-25% SEA, ~35% gross margin; Merries 25-30% premium share, FY2024 babycare OP +4.2%; MegRhythm 40-55% urban share, ~48% gross margin.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eBrand\u003c\/th\u003e\n\u003cth\u003eShare\/Metric (2024-25)\u003c\/th\u003e\n\u003cth\u003eMargin\/EBITDA\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAttack\u003c\/td\u003e\n\u003ctd\u003e46% Japan (2025)\u003c\/td\u003e\n\u003ctd\u003eStable FCF\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eKitchen Care\u003c\/td\u003e\n\u003ctd\u003e52% Japan (2025)\u003c\/td\u003e\n\u003ctd\u003e18-22% EBITDA\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLaurier\u003c\/td\u003e\n\u003ctd\u003e30-40% Japan;15-25% SEA (2025)\u003c\/td\u003e\n\u003ctd\u003e~35% gross\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMerries\u003c\/td\u003e\n\u003ctd\u003e25-30% premium (Euromonitor 2024)\u003c\/td\u003e\n\u003ctd\u003eContributes to OP +4.2% FY2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMegRhythm\u003c\/td\u003e\n\u003ctd\u003e40-55% urban Japan (2025)\u003c\/td\u003e\n\u003ctd\u003e~48% gross\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eDelivered as Shown\u003c\/span\u003e\u003cbr\u003eKao BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing is the exact BCG Matrix report you'll receive after purchase-no watermarks, no placeholders, just the fully formatted, analysis-ready document designed for strategic clarity and immediate use.\u003c\/p\u003e\n\u003cp\u003eThis preview mirrors the final deliverable you'll download: crafted by strategy professionals with market-backed insights, ready for editing, printing, or presenting to stakeholders without further revisions.\u003c\/p\u003e\n\u003cp\u003eWhat you see is the real, one-time-purchase file that will be sent to your inbox-instantly accessible and optimized for business planning, pitch decks, or competitive analysis.\u003c\/p\u003e\n\u003cp\u003eYou're viewing the same professional BCG Matrix document that becomes yours post-purchase-clean, comprehensive, and ready to plug into your workflow with no surprises.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eD\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eogs\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMerries Diapers (China Internal Production)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBy end-2025 Kao ended internal Merries diaper production in China, marking the unit as a Dog: high assets, low market share (under 3% national diaper market) and low growth (\u0026lt;1% CAGR 2023-25).\u003c\/p\u003e\n\u003cp\u003eFacing fierce local rivals and slowing birthrate-driven demand, the unit consumed ~¥6 billion capex and generated negative free cash flow for 2024-25, prompting divestiture to stop the cash trap.\u003c\/p\u003e\n\u003cp\u003eProceeds and saved opex refocus Kao on higher-margin derma-care brands, where gross margins exceed 45% versus diapers around 18%, improving regional profitability.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLow-Margin Hair Salon Brands (AEMEA)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCertain professional hair salon brands in Americas and Europe are classed as Dogs in Kao's BCG matrix after a 2024-2025 traffic decline of ~12% and a 7-9% rise in personnel costs, squeezing gross margins to below 8% and leaving ~60% of partner salons unprofitable.\u003c\/p\u003e\n\u003cp\u003eKao is reviewing these low-margin AEMEA units for reform or divestiture to halt a reported €45-60M annual drag on corporate operating profit in FY2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTraditional Mass-Market Soap Units\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eKao's legacy mass-market soap units in select international markets show low market share and flat-to-declining sales; global bar soap volume fell ~4% in 2024 while liquid handwash grew 7% (Euromonitor). These SKUs often only break even-estimated mid-single-digit EBIT margins-and add little to the K27 quality-based growth model. They are prime candidates for SKU rationalization or market exit to improve Global Consumer Care's 2025 operating margin targets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eJohn Frieda (Non-Core Regions)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eJohn Frieda, a legacy haircare brand, faces aggressive competition and mixed consumer sentiment in several Western markets, leading to low market share and sub-2% CAGR in those regions through 2024.\u003c\/p\u003e\n\u003cp\u003eWhere John Frieda cannot attain a Global Sharp Top position, it risks becoming a Dog that ties up management time while yielding limited returns; Kao is cutting low-margin volume pushes and favoring high-value-added lines instead.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLow growth: sub-2% CAGR (to 2024)\u003c\/li\u003e\n\u003cli\u003eLow share vs premium rivals in Western markets\u003c\/li\u003e\n\u003cli\u003eKao prioritizes high-value SKUs over volume expansion\u003c\/li\u003e\n\u003cli\u003eRisk: consumes resources without adequate ROI\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLegacy Sanitary Assets in Indonesia\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eIntensifying price competition from Indonesian local players has pushed several of Kao's legacy, non-differentiated sanitary products into the Dog quadrant; market share fell ~4-6 percentage points 2022-24 as unit prices dropped 8-12% amid local promotions and private labels.\u003c\/p\u003e\n\u003cp\u003eEconomic slowdown and consumer shift to lower-priced alternatives make growth unlikely; category revenue for these SKUs declined ~15% CAGR 2021-24, prompting Kao to cut marketing spend and inventory allocation.\u003c\/p\u003e\n\u003cp\u003eKao is reallocating resources to differentiated brands like Bioré and Laurier, which grew 7-10% annually 2022-24; legacy sanitary SKUs now receive minimal R\u0026amp;D and trade funding.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eShare decline: -4-6 pp (2022-24)\u003c\/li\u003e\n\u003cli\u003ePrice erosion: -8-12%\u003c\/li\u003e\n\u003cli\u003eRevenue decline: -15% CAGR (2021-24)\u003c\/li\u003e\n\u003cli\u003eGrowth focus: Bioré, Laurier +7-10% CAGR\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eKao under pressure: weak Merries China, loss-making AEMEA salons, declining soap sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBy end-2025 Kao's Dogs: Merries China (market share \u0026lt;3%, \u0026lt;1% CAGR 2023-25, ~¥6bn capex, negative FCF 2024-25); AEMEA salon brands (traffic -12% 2024-25, personnel +7-9%, gross margin \u0026lt;8%, ~60% salons unprofitable, €45-60M annual drag FY2024); legacy soap\/sanitary SKUs (bar soap -4% vol 2024, liquid +7% 2024, sanitary revenue -15% CAGR 2021-24).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eUnit\u003c\/th\u003e\n\u003cth\u003eKey metrics\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMerries China\u003c\/td\u003e\n\u003ctd\u003eShare \u0026lt;3%; \u0026lt;1% CAGR; ¥6bn capex; negative FCF\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAEMEA salons\u003c\/td\u003e\n\u003ctd\u003eTraffic -12%; margin \u0026lt;8%; €45-60M drag\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLegacy soap\/sanitary\u003c\/td\u003e\n\u003ctd\u003eBar -4% vol; sanitary -15% CAGR; price -8-12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eQ\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euestion Marks\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrecision Healthcare and Personalized Medicine\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eKao's precision healthcare unit is a Question Mark: the precision medicine market is forecast to exceed $200 billion by 2028, yet Kao's share is currently negligible, so heavy R\u0026amp;D and capex are needed to turn its interface science into personalized therapies.\u003c\/p\u003e\n\u003cp\u003eSuccess hinges on rapid adoption; assuming a 10% CAGR and Kao captures 0.5-2% within five years, revenue could reach $100-400 million, but low market share and high clinical\/regulatory costs make the outcome uncertain.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMolton Brown (Asian Luxury Market)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMolton Brown is a Question Mark for Kao in Asia: established in Europe but holding a single-digit market share vs LVMH and Estée Lauder in the $55B Asian prestige beauty market (2024, Euromonitor). Kao targets 2x Asian sales by 2027 via integrated operations; that implies CAGR ~25% from 2023 base. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBio IOS Technology Surfactants\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBio IOS Technology Surfactants sits in a high-growth eco-friendly industrial materials market projected to reach $52.5B by 2028, yet it holds low commercial share within Kao's portfolio, classifying it as a Question Mark.\u003c\/p\u003e\n\u003cp\u003eThis moonshot aims to replace petrochemical routes with palm fruit solids-based surfactants, targeting 30-40% CO2-equivalent reductions per lifecycle in pilot LCA tests (2024 data).\u003c\/p\u003e\n\u003cp\u003eAs a Question Mark it consumes cash-Kao committed roughly JPY 5.0B (≈$35M) to scale-up through 2024-25-and needs industrial client adoption to scale volumes.\u003c\/p\u003e\n\u003cp\u003eIf large clients don't adopt production change, the asset risks becoming a niche Dog; break-even requires \u0026gt;10kt\/year plant utilization and contracts securing ~€20-25M annual revenue by 2027.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect-to-Consumer (D2C) Business Connected Division\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe Business Connected Division is a Question Mark: launched in 2023 to enable co-creation and direct-to-consumer (D2C) sales, it targets high-growth beauty and health D2C markets projected at ~9-11% CAGR to 2028.\u003c\/p\u003e\n\u003cp\u003eKao's D2C share remains small-estimated under 3% of group revenue in FY2024 (~¥20bn of ¥680bn total sales)-so the unit needs scale to become a Star.\u003c\/p\u003e\n\u003cp\u003eKao is testing scrum-style operations and agile sprints to cut launch time from ~9 months to 3-4 months; success metrics: CAC, repeat purchase rate, and gross margin expansion.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLaunched 2023 as Question Mark\u003c\/li\u003e\n\u003cli\u003eBeauty\/health D2C CAGR ~9-11% to 2028\u003c\/li\u003e\n\u003cli\u003eD2C ≈3% of Kao revenue in FY2024 (~¥20bn)\u003c\/li\u003e\n\u003cli\u003eGoal: reduce launch time 9→3-4 months via scrum\u003c\/li\u003e\n\u003cli\u003eKey KPIs: CAC, repeat rate, gross margin\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePFAS-free Fire Extinguishing Agents\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eKao's interface control tech powers PFAS-free fire extinguishing agents aimed at a global sustainability market valued at ~$1.2B in 2024 for fluorine-free firefighting foams; the unit has low market share while navigating EU REACH and US EPA rules and early commercial trials.\u003c\/p\u003e\n\u003cp\u003eThis Question Mark has high upside-if growth hits 30-40% CAGR with scale it could become a Star in green-tech; failure to secure regulatory approvals or customers would prompt divestment.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 market ~1.2B; PFAS phase-outs rising\u003c\/li\u003e\n\u003cli\u003eCurrent market share: low (single-digit %)\u003c\/li\u003e\n\u003cli\u003eTarget CAGR to Star: 30-40%\u003c\/li\u003e\n\u003cli\u003eKey risks: REACH, EPA approval, adoption lag\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eKao's Question Marks: high-growth markets, low share-scale fast or face decline\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eKao's Question Marks-precision healthcare, Molton Brown Asia, Bio IOS surfactants, D2C Business Connected, PFAS-free firefighting-face high-growth markets (precision med \u0026gt;$200B by 2028; Asian prestige beauty $55B 2024; eco-surfactants $52.5B 2028; D2C beauty CAGR ~9-11%; firefighting foams ~$1.2B 2024) but hold low shares; each needs rapid scale, regulatory wins, or customer contracts to become Stars or risk becoming Dogs.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eUnit\u003c\/th\u003e\n\u003cth\u003eMarket 2024\/28\u003c\/th\u003e\n\u003cth\u003eKao share\u003c\/th\u003e\n\u003cth\u003eKey target\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrecision healthcare\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;$200B by 2028\u003c\/td\u003e\n\u003ctd\u003enegligible\u003c\/td\u003e\n\u003ctd\u003e0.5-2% (5y)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMolton Brown Asia\u003c\/td\u003e\n\u003ctd\u003e$55B (2024)\u003c\/td\u003e\n\u003ctd\u003esingle-digit%\u003c\/td\u003e\n\u003ctd\u003e2x sales by 2027 (≈25% CAGR)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBio IOS surfactants\u003c\/td\u003e\n\u003ctd\u003e$52.5B by 2028\u003c\/td\u003e\n\u003ctd\u003elow\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;10kt\/yr, €20-25M rev by 2027\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eD2C Business Connected\u003c\/td\u003e\n\u003ctd\u003e9-11% CAGR\u003c\/td\u003e\n\u003ctd\u003e≈3% group rev (¥20bn)\u003c\/td\u003e\n\u003ctd\u003ecut launch 9→3-4 months\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePFAS-free foams\u003c\/td\u003e\n\u003ctd\u003e$1.2B (2024)\u003c\/td\u003e\n\u003ctd\u003esingle-digit%\u003c\/td\u003e\n\u003ctd\u003e30-40% CAGR to scale\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"BCG Matrix","offers":[{"title":"Default Title","offer_id":44508940795987,"sku":"kao-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0709\/3102\/1907\/files\/kao-bcg-matrix.webp?v=1776723735","url":"https:\/\/bcgmatrixtemplate.com\/products\/kao-bcg-matrix","provider":"BCG Matrix","version":"1.0","type":"link"}